Ironwood Pharmaceuticals Inc (IRWD) SEC Filings — 2024
25 SEC filings for Ironwood Pharmaceuticals Inc (IRWD) in 2024.
Filings
- Ironwood Pharma Appoints New CFO, Adds Directors — 8-K · Dec 5, 2024
- Ironwood Pharmaceuticals Inc SC 13G Filing — SC 13G · Nov 14, 2024
- Ironwood Pharma Elects New Directors, Adjusts CMO Compensation — 8-K · Nov 12, 2024
- Ironwood Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Ironwood Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Ironwood Pharmaceuticals Files 8-K on Financials — 8-K · Nov 7, 2024
- Ironwood Pharma Q3 Sales Hit $800K — 10-Q · Nov 7, 2024
- Ironwood Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Ironwood Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Oct 23, 2024
- Ironwood Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Oct 16, 2024
- Ironwood Pharmaceuticals Enters Material Agreement, Creates Financial Obligation — 8-K · Sep 30, 2024
- Ironwood Pharmaceuticals Files 8-K on Financials — 8-K · Aug 8, 2024
- Ironwood Pharma Q2 2024 10-Q Filed — 10-Q · Aug 8, 2024
- Ironwood Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 21, 2024
- Ironwood Pharmaceuticals Appoints New CFO — 8-K · Jun 20, 2024
- Ironwood Pharmaceuticals Files 8-K on Financials — 8-K · May 9, 2024
- Ironwood Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Ironwood Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 25, 2024
- Ironwood Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 16, 2024
- Ironwood Pharma Files 8-K on Q4 Results & Financial Condition — 8-K · Feb 15, 2024
- LSV Asset Management Amends Ironwood Pharma Stake Filing — SC 13G/A · Feb 9, 2024
- State Street Lowers Passive Stake in Ironwood Pharma to 6.4% — SC 13G/A · Jan 25, 2024
- BlackRock Updates Passive Stake in Ironwood Pharma (IRWD) — SC 13G/A · Jan 22, 2024
- Vanguard Amends Ironwood Pharma Stake, Signals Continued Ownership — SC 13G/A · Jan 10, 2024
- IRWD Files 8-K for M&A/Tender Offer Related Communications — 8-K · Jan 8, 2024